MedPath
HSA Approval

BENZYL BENZOATE APPLICATION BP 25% w/v

SIN06735P

BENZYL BENZOATE APPLICATION BP 25% w/v

BENZYL BENZOATE APPLICATION BP 25% w/v

December 13, 1991

ICM PHARMA PTE. LTD.

ICM PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantICM PHARMA PTE. LTD.
Licence HolderICM PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

EMULSION

TOPICAL

Medical Information

P03AX01

benzyl benzoate

Manufacturer Information

ICM PHARMA PTE. LTD.

ICM PHARMA PTE. LTD.

Active Ingredients

BENZYL BENZOATE

25% w/v

Benzyl benzoate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BENZYL BENZOATE APPLICATION BP 25% w/v - HSA Approval | MedPath